Hedman A, Alván G, Strandvik B, Arvidsson A
Department of Clinical Pharmacology, Karolinska Institutet, Huddinge University Hospital, Sweden.
Clin Pharmacokinet. 1990 Feb;18(2):168-75. doi: 10.2165/00003088-199018020-00006.
The steady-state renal clearance of cefsulodin was studied in 6 patients with cystic fibrosis and 8 healthy controls. The drug was administered by constant rate infusion to obtain 2 values of plasma concentration, 2 and 30 mg/L. As an estimate of the glomerular filtration rate, the renal clearance of inulin was measured simultaneously. The results showed the figures for inulin clearance to be approximately 30% higher in cystic fibrosis patients than in healthy controls at both concentrations, and a corresponding increase in the renal clearance of cefsulodin was seen in patients over controls. The ratio between the renal clearances of the 2 substances was on average 0.9 in both groups. The correlation found between the 2 renal clearances (r = 0.75; p less than 0.001) indicates that glomerular filtration rate has considerable influence on the renal elimination of cefsulodin. This finding emphasises the importance of glomerular filtration rate for the renal clearance of drugs in cystic fibrosis.
在6名囊性纤维化患者和8名健康对照者中研究了头孢磺啶的稳态肾清除率。通过恒速输注给药该药物以获得2个血浆浓度值,即2和30mg/L。作为肾小球滤过率的估计值,同时测量菊粉的肾清除率。结果显示,在两种浓度下,囊性纤维化患者的菊粉清除率数字均比健康对照者高约30%,并且与对照相比,患者的头孢磺啶肾清除率相应增加。两组中两种物质的肾清除率之比平均为0.9。两种肾清除率之间的相关性(r = 0.75;p小于0.001)表明肾小球滤过率对头孢磺啶的肾排泄有相当大的影响。这一发现强调了肾小球滤过率对囊性纤维化患者药物肾清除率的重要性。